Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Beta Bionics (BBNX) Research & Development (2024 - 2025)

Historic Research & Development for Beta Bionics (BBNX) over the last 2 years, with Q3 2025 value amounting to $8.2 million.

  • Beta Bionics' Research & Development rose 5940.48% to $8.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.9 million, marking a year-over-year change of. This contributed to the annual value of $26.2 million for FY2024, which is 4592.88% up from last year.
  • Beta Bionics' Research & Development amounted to $8.2 million in Q3 2025, which was up 5940.48% from $8.9 million recorded in Q2 2025.
  • Over the past 5 years, Beta Bionics' Research & Development peaked at $9.2 million during Q4 2024, and registered a low of $5.1 million during Q3 2024.